FineMark National Bank & Trust Lowers Holdings in HCA Healthcare, Inc. (NYSE:HCA)

FineMark National Bank & Trust trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA) by 1.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,555 shares of the company’s stock after selling 42 shares during the quarter. FineMark National Bank & Trust’s holdings in HCA Healthcare were worth $1,067,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of the business. Cerity Partners LLC lifted its stake in shares of HCA Healthcare by 21.9% during the third quarter. Cerity Partners LLC now owns 29,695 shares of the company’s stock worth $12,069,000 after purchasing an additional 5,340 shares in the last quarter. Larson Financial Group LLC boosted its stake in shares of HCA Healthcare by 201.3% in the third quarter. Larson Financial Group LLC now owns 672 shares of the company’s stock valued at $273,000 after purchasing an additional 449 shares during the period. Harvest Fund Management Co. Ltd lifted its stake in shares of HCA Healthcare by 3.1% in the third quarter. Harvest Fund Management Co. Ltd now owns 1,778 shares of the company’s stock worth $723,000 after acquiring an additional 53 shares in the last quarter. Independent Advisor Alliance grew its stake in HCA Healthcare by 20.5% during the 3rd quarter. Independent Advisor Alliance now owns 1,142 shares of the company’s stock valued at $464,000 after purchasing an additional 194 shares in the last quarter. Finally, Hancock Whitney Corp boosted its stake in shares of HCA Healthcare by 5.2% during the 3rd quarter. Hancock Whitney Corp now owns 4,111 shares of the company’s stock valued at $1,671,000 after buying an additional 205 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

HCA has been the topic of several recent analyst reports. Bank of America cut their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Royal Bank of Canada lowered their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. Morgan Stanley lowered their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. Barclays decreased their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a report on Monday, January 27th. Finally, KeyCorp decreased their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $385.67.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.60% of the stock is owned by insiders.

HCA Healthcare Trading Up 0.7 %

NYSE:HCA opened at $336.12 on Wednesday. The stock has a market cap of $82.75 billion, a price-to-earnings ratio of 15.30, a PEG ratio of 1.10 and a beta of 1.68. The business has a fifty day moving average of $322.63 and a 200-day moving average of $341.89. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the company posted $5.90 earnings per share. Equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.86%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.